LAB
Standard Biotools Inc
0.7498$
+1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.7% | +111.0% | +65.6% | +32.1% | +27.7% | +22.1% | +36.0% | +63.6% | -1.5% | -8.9% | -2.4% | +10.8% | +3.8% | +17.8% | -5.5% | -25.0% | +8.6% | +64.0% | -51.1% | |
| – | +26.7% | +138.0% | +37.3% | +0.8% | +13.9% | +16.2% | +31.0% | +113.4% | +8.8% | -1.3% | +8.6% | +2.7% | +3.2% | +3.5% | -2.7% | +14.2% | -8.2% | +61.3% | -52.5% | |
| – | +3.8% | +85.7% | +99.4% | +57.8% | +35.0% | +24.7% | +38.1% | +44.0% | -7.5% | -14.2% | -11.0% | +18.6% | +4.3% | +29.6% | -7.3% | -52.0% | +36.2% | +67.0% | -49.5% | |
| – | -7.7% | -2.6% | -12.1% | +5.6% | +7.1% | +19.1% | +18.8% | +120.1% | -9.6% | -2.2% | -19.8% | -2.6% | +5.4% | +15.2% | +4.1% | -1.5% | -30.6% | +140.5% | -58.4% | |
| – | – | – | – | – | – | – | – | – | – | – | -14.7% | +0.3% | +5.9% | +15.9% | +1.0% | +16.0% | -13.8% | +58.4% | -29.8% | |
| – | +7.9% | +33.9% | -12.5% | +14.4% | +23.8% | +21.8% | +23.1% | +69.3% | +6.5% | +7.7% | -16.2% | -0.5% | +5.7% | +15.7% | +7.7% | +5.9% | -17.1% | +104.2% | -47.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.4% | -27.2% | +41.6% | -25.0% | +43.7% | -79.7% | -97.8% | +38,071.4% | +8.7% | +0.2% | +0.1% | +138.5% | -69.2% | -16.5% | +7.0% | +13.3% | +5.4% | -27.4% | -99.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -45.9% | -240.0% | – | – | +100.0% | -18.1% | +0.7% | -3,658.4% | – | – | – | – | – | – | – | – | – | +26.8% | -6,710.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.